z-logo
Premium
Identification of a genotoxic mechanism for the carcinogenicity of the environmental pollutant and suspected human carcinogen o ‐anisidine
Author(s) -
Stiborová Marie,
Mikšanová Markéta,
Šulc Miroslav,
Rýdlová Helena,
Schmeiser Heinz H.,
Frei Eva
Publication year - 2005
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.21122
Subject(s) - carcinogen , microsome , metabolite , chemistry , dna , biochemistry , deoxyguanosine , genotoxicity , dna adduct , cyp2e1 , adduct , in vivo , in vitro , microbiology and biotechnology , toxicity , biology , organic chemistry
2‐methoxyaniline ( o ‐anisidine) is an industrial and environmental pollutant and a bladder carcinogen for rodents. The mechanism of its carcinogenicity was investigated with 2 independent methods, 32 P‐postlabeling and 14 C‐labeled o ‐anisidine, to show that o ‐anisidine binds covalently to DNA in vitro after its activation by human hepatic microsomes. We also investigated the capacity of o ‐anisidine to form DNA adducts in vivo . Rats were treated i.p. with o ‐anisidine (0.15 mg/kg daily for 5 days) and DNA from several organs was analyzed by 32 P‐postlabeling. Two o ‐anisidine‐DNA adducts, identical to those found in DNA incubated with o ‐anisidine and human microsomes in vitro , were detected in urinary bladder (4.1 adducts per 10 7 nucleotides), the target organ, and, to a lesser extent, in liver, kidney and spleen. These DNA adducts were identified as deoxyguanosine adducts derived from a metabolite of o ‐anisidine, N ‐(2‐methoxyphenyl)hydroxylamine. This metabolite was identified in incubations with human microsomes. With 9 human hepatic microsomal preparations, we identified the specific CYP catalyzing the formation of the o ‐anisidine metabolites by correlation studies and by examining the effects of CYP inhibitors. On the basis of these analyses, oxidation of o ‐anisidine was attributed mainly to CYP2E1. Using recombinant human CYP (in Supersomes) and purified CYPs, the participation of CYP2E1 in o ‐anisidine oxidation was confirmed. In Supersomes, CYP1A2 was even more efficient in oxidizing o ‐anisidine than CYP2E1, followed by CYP2B6, 1A1, 2A6, 2D6 and 3A4. The results, the first report on the potential of the human microsomal CYP enzymes to activate o ‐anisidine, strongly suggest a carcinogenic potential of this rodent carcinogen for humans. © 2005 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom